logo







Home>Companies>Moderna-therapeutics


Moderna therapeutics

Moderna therapeutics



Moderna Therapeutics is a biotechnology company specializing in mRNA technology to develop innovative vaccines and therapeutics across various therapeutic areas, including infectious diseases, oncology, cardiovascular diseases, and rare genetic disorders.
Sign up today to get real-time market insights on Moderna therapeutics and hundreds of other pre-IPO companies



Moderna therapeutics Overview

Cambridge, MA, United States
2010
Biotech
https://www.modernatx.com



Moderna therapeutics Live Market Data

$00000000
$00000000




Moderna therapeutics Funding Rounds



RoundDateAmount RaisedValuationInvestorsSources
Secondary Transaction - Open Market3/1/2021
Secondary Transaction - Open Market12/2/2020
IPO12/7/2018
Series H5/4/2018
Series G2/1/2018
Series F
9/7/2016




Moderna therapeutics Investors



InvestorInvestment RoundsLead PartnerInitial InvestmentOther Notable Investments
Fidelity InvestmentsSeries E, Series D, Series GSeries E (2015-01-05)
Flagship PioneeringSeries D, Series GSeries D (2014-01-22)
Viking Global InvestorsSeries E, Series GSeries E (2015-01-05)
Wellington ManagementSeries ESeries E (2015-01-05)
ADS VenturesSeries GSeries G (2018-02-01)
ArrowMark PartnersSeries GSeries G (2018-02-01)
EDBI
Series G
Series G (2018-02-01)




Moderna therapeutics 409a Valuations



DatePrice per shareEst. ValuationFilling
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Sign up to access Moderna therapeutics data




Moderna therapeutics Filings



TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign up to access Moderna therapeutics data








Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.